Search research articles
Contact Us
Filters
Showing results (51-60 of 251) with videos related to
Page
of 26
Sort By:
Human Gene Therapy
|
November 26, 2020
Central Nervous System Therapeutic Targets in Friedreich Ataxia
Ian H Harding, David R Lynch, Arnulf H Koeppen, et al.
Journal of Child Neurology
|
July 27, 2012
Unanswered questions in Friedreich ataxia
David R Lynch, Eric C Deutsch, Robert B Wilson, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
|
December 5, 2002
Contrast letter acuity as a measure of visual dysfunction in patients with Friedreich ataxia
David R Lynch, Jennifer M Farmer, Dustin Rochestie, et al.
The Journal of Biological Chemistry
|
April 27, 2007
N-methyl-D-aspartate receptor-dependent regulation of the glutamate transporter excitatory amino acid carrier 1
Elisa A Waxman, Isabelle Baconguis, David R Lynch, et al.
Neurology. Genetics
|
May 27, 2022
Clinical Evidence for Variegated Silencing in Patients With Friedreich Ataxia
Layne N Rodden, Christian Rummey, Yi Na Dong, et al.
Journal of Multidisciplinary Healthcare
|
July 8, 2021
Friedreich Ataxia: Multidisciplinary Clinical Care
David R Lynch, Kim Schadt, Elizabeth Kichula, et al.
Journal of Child Neurology
|
March 13, 2012
Cardiac dysfunction exacerbated by endocrinopathies in Friedreich ataxia: a case series
Madeline Snyder, Lauren Seyer, David R Lynch, et al.
CNS Drugs
|
March 27, 2009
Pharmacotherapy for Friedreich ataxia
Amy Y Tsou, Lisa S Friedman, Robert B Wilson, et al.
Neurodegenerative Disease Management
|
December 25, 2025
Neuropathology of Friedreich ataxia and its links to metabolic pathways
Elizabeth Mercado-Ayón, Michael P Lazaropoulos, Yesica Mercado-Ayón, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
July 6, 2012
miR-886-3p levels are elevated in Friedreich ataxia
Lata H Mahishi, Ronald P Hart, David R Lynch, et al.
Page
of 26
Search research articles
Search
Showing results (51-60 of 251) with videos related to
Sort By:
Page
of 26
Human Gene Therapy
|
November 26, 2020
Central Nervous System Therapeutic Targets in Friedreich Ataxia
Ian H Harding, David R Lynch, Arnulf H Koeppen, et al.
Journal of Child Neurology
|
July 27, 2012
Unanswered questions in Friedreich ataxia
David R Lynch, Eric C Deutsch, Robert B Wilson, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
|
December 5, 2002
Contrast letter acuity as a measure of visual dysfunction in patients with Friedreich ataxia
David R Lynch, Jennifer M Farmer, Dustin Rochestie, et al.
The Journal of Biological Chemistry
|
April 27, 2007
N-methyl-D-aspartate receptor-dependent regulation of the glutamate transporter excitatory amino acid carrier 1
Elisa A Waxman, Isabelle Baconguis, David R Lynch, et al.
Neurology. Genetics
|
May 27, 2022
Clinical Evidence for Variegated Silencing in Patients With Friedreich Ataxia
Layne N Rodden, Christian Rummey, Yi Na Dong, et al.
Journal of Multidisciplinary Healthcare
|
July 8, 2021
Friedreich Ataxia: Multidisciplinary Clinical Care
David R Lynch, Kim Schadt, Elizabeth Kichula, et al.
Journal of Child Neurology
|
March 13, 2012
Cardiac dysfunction exacerbated by endocrinopathies in Friedreich ataxia: a case series
Madeline Snyder, Lauren Seyer, David R Lynch, et al.
CNS Drugs
|
March 27, 2009
Pharmacotherapy for Friedreich ataxia
Amy Y Tsou, Lisa S Friedman, Robert B Wilson, et al.
Neurodegenerative Disease Management
|
December 25, 2025
Neuropathology of Friedreich ataxia and its links to metabolic pathways
Elizabeth Mercado-Ayón, Michael P Lazaropoulos, Yesica Mercado-Ayón, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
July 6, 2012
miR-886-3p levels are elevated in Friedreich ataxia
Lata H Mahishi, Ronald P Hart, David R Lynch, et al.
Page
of 26